Blood pressure medication recall expanded
The FDA announced that Teva Pharmaceuticals USA has expanded its voluntary recall of certain blood pressure medication.
The medication was initially recalled on April 25, 2019. This expanded recall includes six lots of bulk losartan potassium USP Tablets (two lots of 50 mg strength and four lots of 100 mg strength) due to the detection of an impurity.
The affected losartan potassium tablets being recalled are described as:
- Losartan potassium tablets, USP 50 mg, are green, film-coated, oval-shaped biconvex tablets with “LK 50” on one side and ">" on the other side.
- Losartan potassium tablets, USP 100 mg, are dark green, film-coated, oval-shaped biconvex tablets with “LK100” on one side and ">" on the other side.
Health officials recommend contacting your doctor before making any changes to your medication.